Plain-English translation of NCT07063212 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether combined with can help people with head and neck cancer that has returned or spread to other parts of the body after their first round of treatment. Both drugs work in different ways to fight cancer cells. The study wants to learn if using them together is safe and effective for your type of cancer.
Many people with advanced head and neck cancer stop responding to their first treatment. This medication combination offers a new approach that hasn't been thoroughly tested in this patient group yet, and doctors hope it may help people whose cancer continues to grow despite standard therapies.
You likely qualify if…
You likely don't qualify if…
You would receive the two cancer drugs as infusions (through an IV) on a set schedule determined by the study doctors. You would have regular clinic visits for blood tests, physical exams, and imaging scans to check how your cancer is responding to the treatment. The study will monitor you closely for side effects and adjust your treatment as needed based on how you're doing.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States